Literature DB >> 15749911

The cytokine IL-1beta activates IFN response factor 3 in human fetal astrocytes in culture.

Mark A Rivieccio1, Gareth R John, Xianyuan Song, Hyeon-Sook Suh, Yongmei Zhao, Sunhee C Lee, Celia F Brosnan.   

Abstract

The cytokine IL-1beta is a major activator of primary human fetal astrocytes in culture, leading to the production of a wide range of cytokines and chemokines important in the host defense against pathogens. IL-1beta, like TLR4, signals via the MyD88/IL-1betaR-associated kinase-1 pathway linked to activation of NF-kappaB and AP-1. Recent studies have shown that TLR4 also signals independently of MyD88, resulting in the activation of IFN regulatory factor 3 (IRF3), a transcription factor required for the production of primary antiviral response genes such as IFN-beta. Using a functional genomics approach, we observed that IL-1beta induced in astrocytes a group of genes considered to be IFN-stimulated genes (ISG), suggesting that IL-1beta may also signal via IRF3 in these cells. We now show, using real-time PCR, that in astrocytes IL-1beta induces the expression of IFN-beta, IRF7, CXCL10/IFN-gamma-inducible protein-10, and CCL5/RANTES. Chemokine expression was confirmed by ELISA. We also show that IL-1beta induces phosphorylation and nuclear translocation of IRF3 and delayed phosphorylation of STAT1. The dependency of IFN-beta, IRF7, and CXCL10/IFN-gamma-inducible protein-10 gene expression on IRF3 was confirmed using a dominant negative IRF3-expressing adenovirus. The robust induction by IL-1beta of additional ISG noted on the microarrays, such as STAT1, 2'5'-oligoadenylate synthetase 2, and ISG15, also supports an active signaling role for IL-1beta via this pathway in human fetal astrocytes. These data are the first to show that IL-1beta, in addition to TLRs, can stimulate IRF3, implicating this cytokine as an activator of genes involved in innate antiviral responses in astrocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749911     DOI: 10.4049/jimmunol.174.6.3719

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Authors:  Leonid Tarassishin; Olivier Loudig; Avital Bauman; Bridget Shafit-Zagardo; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2011-12       Impact factor: 7.452

2.  Involvement of CLEC16A in activation of astrocytes after LPS treated.

Authors:  Xinmin Wu; Jing Li; Chun Chen; Yaohua Yan; Shengyang Jiang; Xiaohong Wu; Bai Shao; Jin Xu; Lihua Kang; Yeqing Huang; Lin Zhu; Yuhong Ji; Yilu Gao
Journal:  Neurochem Res       Date:  2011-10-15       Impact factor: 3.996

3.  The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways.

Authors:  Yongmei Zhao; Mark A Rivieccio; Sarah Lutz; Eliana Scemes; Celia F Brosnan
Journal:  Glia       Date:  2006-12       Impact factor: 7.452

4.  Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes.

Authors:  Hongwei Qin; Sandrine A Niyongere; Sun Jung Lee; Brandi J Baker; Etty N Benveniste
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

5.  Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppression.

Authors:  Jinbo Gao; Yujun Wang; Quanhua Xing; Jin Yan; Maheswari Senthil; Yasir Akmal; Claudia M Kowolik; Julia Kang; David M Lu; Ming Zhao; Zhixiu Lin; Christopher H K Cheng; M L Richard Yip; John H Yim
Journal:  Mol Cancer Ther       Date:  2011-08-04       Impact factor: 6.261

6.  The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Authors:  Randall L Davis; Subhas Das; J Thomas Curtis; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

7.  Involvement of CtBP2 in LPS-induced microglial activation.

Authors:  Guowei Zhang; Yaohua Yan; Lihua Kang; Qi Cao; Kaifu Ke; Xinmin Wu; Yilu Gao; Qinglei Hang; Chunmiao Li; Lin Zhu; Qin Yuan; Qiyun Wu; Chun Cheng
Journal:  J Mol Histol       Date:  2012-03-17       Impact factor: 2.611

8.  FOXJ2 expression in rat spinal cord after injury and its role in inflammation.

Authors:  Xiang Chen; Xingjian Cao; Guohua Tao; Zhaoming Cao; Shuo Wang; Feng Zhou; Wei Xie; Peng Zhao; Zheping Zhang; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2012-01-13       Impact factor: 3.444

9.  Network analysis of human glaucomatous optic nerve head astrocytes.

Authors:  Tatiana Nikolskaya; Yuri Nikolsky; Tatiana Serebryiskaya; Svetlana Zvereva; Eugene Sviridov; Zoltan Dezso; Eugene Rahkmatulin; Richard J Brennan; Nick Yankovsky; Sanjoy K Bhattacharya; Olga Agapova; M Rosario Hernandez; Valery I Shestopalov
Journal:  BMC Med Genomics       Date:  2009-05-09       Impact factor: 3.063

10.  Spatiotemporal pattern of RNA-binding motif protein 3 expression after spinal cord injury in rats.

Authors:  Wei Zhao; Dawei Xu; Gang Cai; Xinhui Zhu; Ming Qian; Wei Liu; Zhiming Cui
Journal:  Cell Mol Neurobiol       Date:  2014-02-26       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.